State of Wisconsin Investment Board’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

State of Wisconsin Investment Board’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-41,300	Closed	-$1.4M	–	2208
2021 Q2	$1.4M	Hold	41,300	–	–	﹤0.01%	1362
2021 Q1	$966K	Sell	41,300 -1,700	-4%	-$51.5K	﹤0.01%	1375
2020 Q4	$1.24M	Sell	43,000 -17,000	-28%	-$428K	﹤0.01%	1280
2020 Q3	$1.22M	Buy	60,000 +26,400	+79%	+$645K	﹤0.01%	1250
2020 Q2	$1.01M	Buy	33,600 +4,400	+15%	+$158K	﹤0.01%	1242
2020 Q1	$918K	Buy	+29,200	New	+$1.02M	﹤0.01%	1218
2019 Q3	–	Sell	-23,000	Closed	-$282K	–	1598
2019 Q2	$282K	Buy	+23,000	New	+$256K	﹤0.01%	1449

State of Wisconsin Investment Board's CNST Position: Q3 2021 in Review

State of Wisconsin Investment Board sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 41,300 shares — an estimated $1.4M sold.

State of Wisconsin Investment Board first reported a position in CNST in Q2 2019 and held it in 7 quarters. The position peaked at $1.4M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

State of Wisconsin Investment Board reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
State of Wisconsin Investment Board sold 41,300 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1.4M.
State of Wisconsin Investment Board first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2019 and held it in 7 quarters.
State of Wisconsin Investment Board's Constellation Pharmaceuticals, Inc. position peaked at $1.4M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2021, filed 12 Nov 2021.